Lupus & antiphospholipid syndrome

Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria

Semin Arthritis RheumPublished Retrospective cohort study

Authors' conclusion

Our findings highlight distinct clinical profiles in triple aPL-positive patients based on aCL/aβ2GPI isotypes. While IgG (±IgM) isotypes were associated with higher clinical domain scores and severe manifestations, the role of IgM-only isotypes warrants further mechanistic and clinical investigation even in triple aPL profile.

Study context

Population
Triple aPL-positive patients (persistently positive LA, aCL IgG/M ≥ 40 ELISA Units, aβ2GPI IgG/M ≥ 40 ELISA Units), Antiphospholipid Syndrome (APS)-specialized practice cohort, Feb 2016-May 2024of 751 patients in cohort
Participants
193 patients
Exposure
aCL/aβ2GPI IgG vs IgM-only in triple aPL-positive patients
  • IgG (±IgM)n = 165
  • IgM-onlyn = 28reference
Outcome
Clinical domain involvement (2023 ACR/EULAR APS CC), all triple aPL-positive
Methodological detailsAPS-specialized practice cohort
  • APS-specialized practice cohort

Main finding

As reported in the abstract

Macrovascular VTE
46 %
Macrovascular arterial thrombosis
39 %
Microvascular
35 %
Obstetric
46 %
Cardiac valve
16 %
Hematologic
34 %

Observational data: associations, not effects.

Further findings

IgG (±IgM) had significantly higher 2023 ACR/EULAR Classification Criteria (CC) total clinical domain score, greater macrovascular and microvascular involvement, and higher use of long-term anticoagulation, steroids and immunosuppression vs IgM-only
Almost half of IgM-only patients, who were older, lacked clinical domain involvement

Original publication

Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Semin Arthritis Rheum. Published 5 June 2025. doi:10.1016/j.semarthrit.2025.152768

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.